Srdjan R. Stankovic Acadia Pharmaceuticals Inc (ACAD) insider trading activity

ACAD Quotes by TradingView

Srdjan R. Stankovic is President of ACADIA PHARMACEUTICALS INC. Currently has a direct ownership of 61,234 shares of ACAD, which is worth approximately $1.05 Million. The most recent transaction as insider was on Nov 21, 2022, when has been sold 1,847 shares (Common Stock) at a price of $15.07 per share, resulting in proceeds of $27,834. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 61.2K
0% 3M change
0% 12M change
Total Value Held $1.05 Million

Srdjan R. Stankovic Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 21 2022
SELL
Open market or private sale
$27,834 $15.07 p/Share
1,847 Reduced 2.93%
61,234 Common Stock
Nov 19 2022
BUY
Exercise of conversion of derivative security
-
6,250 Added 9.01%
63,081 Common Stock
Oct 15 2022
SELL
Open market or private sale
$20,964 $15.81 p/Share
1,326 Reduced 2.28%
56,831 Common Stock
Oct 15 2022
BUY
Exercise of conversion of derivative security
-
2,969 Added 4.86%
58,157 Common Stock
May 02 2022
SELL
Open market or private sale
$52,086 $18.18 p/Share
2,865 Reduced 4.94%
55,188 Common Stock
Apr 29 2022
BUY
Exercise of conversion of derivative security
-
9,616 Added 14.21%
58,053 Common Stock
Feb 23 2022
SELL
Open market or private sale
$35,724 $23.8 p/Share
1,501 Reduced 3.01%
48,437 Common Stock
Feb 23 2022
BUY
Exercise of conversion of derivative security
-
4,919 Added 8.97%
49,938 Common Stock
Jan 06 2022
SELL
Open market or private sale
$44,648 $23.05 p/Share
1,937 Reduced 4.13%
45,019 Common Stock
Jan 06 2022
BUY
Exercise of conversion of derivative security
-
5,444 Added 10.39%
46,956 Common Stock
Nov 22 2021
SELL
Open market or private sale
$53,285 $19.01 p/Share
2,803 Reduced 6.33%
41,512 Common Stock
Nov 19 2021
BUY
Exercise of conversion of derivative security
-
6,250 Added 12.36%
44,315 Common Stock
Oct 18 2021
SELL
Open market or private sale
$23,295 $17.41 p/Share
1,338 Reduced 3.4%
38,065 Common Stock
Oct 15 2021
BUY
Exercise of conversion of derivative security
-
2,969 Added 7.01%
39,403 Common Stock
Apr 30 2021
SELL
Open market or private sale
$85,996 $20.33 p/Share
4,230 Reduced 10.4%
36,434 Common Stock
Apr 29 2021
BUY
Exercise of conversion of derivative security
-
9,615 Added 19.12%
40,664 Common Stock
Feb 04 2021
SELL
Open market or private sale
$426,592 $50.61 p/Share
8,429 Reduced 21.35%
31,049 Common Stock
Feb 04 2021
BUY
Grant, award, or other acquisition
-
19,231 Added 32.76%
39,478 Common Stock
Jan 12 2021
SELL
Open market or private sale
$38,507 $55.01 p/Share
700 Reduced 3.34%
20,247 Common Stock
Jan 12 2021
BUY
Exercise of conversion of derivative security
$12,684 $18.12 p/Share
700 Added 3.23%
20,947 Common Stock
Jan 08 2021
SELL
Open market or private sale
$1,641,856 $55.22 p/Share
29,733 Reduced 59.49%
20,247 Common Stock
Jan 08 2021
BUY
Exercise of conversion of derivative security
$745,406 $25.07 p/Share
29,733 Added 37.3%
49,980 Common Stock
Jan 07 2021
SELL
Open market or private sale
$3,396,439 $55.12 p/Share
61,619 Reduced 75.27%
20,247 Common Stock
Jan 07 2021
BUY
Exercise of conversion of derivative security
$2,205,960 $35.8 p/Share
61,619 Added 42.94%
81,866 Common Stock
Jan 06 2021
SELL
Open market or private sale
$92,012 $53.34 p/Share
1,725 Reduced 7.85%
20,247 Common Stock
SRS

Srdjan R. Stankovic

President
San Diego, CA

Track Institutional and Insider Activities on ACAD

Follow ACADIA PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACAD shares.

Notify only if

Insider Trading

Get notified when an Acadia Pharmaceuticals Inc insider buys or sells ACAD shares.

Notify only if

News

Receive news related to ACADIA PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ACAD